LINC01638

Across TCGA pan-cancer cohorts, LINC01638 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01638’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01638 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01638 is over-expressed in tumor, although a few such as UCEC and BLCA show the opposite, repressed pattern.

KIRC, LUAD, and UCEC are the cancer types where LINC01638 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01638 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+1.385	<.001	11	view →
LUAD	Female	II,III,IV	+0.756	<.001	10	view →
UCEC	All	All	−0.712	<.001	8	view →
KIRP	All	All	+0.291	.010	8	view →
COAD	All	All	+0.263	.007	6	view →
BRCA	Female	All	+0.191	.017	6	view →
BLCA	Male	III,IV	−0.785	.007	4	view →
PAAD	Male	All	−0.779	.004	2	view →
READ	All	III,IV	−0.299	.028	2	view →
LUSC	All	All	+0.225	.016	2	view →
HNSC	Female	IV	+0.761	.030	1	view →
CHOL	All	All	+0.566	.011	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01638–KIRC

Open the KIRC breakdown →